All this talk about quarterly earnings and venture stats reminded me: I never posted my favorite stories from Xconomy Boston’s third quarter.
Yes, I know it’s almost the end of October, and the third quarter ended a month ago. I must have been traumatized by the collapse of the Red Sox or something (is baseball still going on?). Go ahead, run me out of town like Theo and Tito.
This time, I’m not consulting with my colleagues. I’m a rebel, a maverick. I work alone. Without further ado, here are my favorite stories from July through September:
Top 10 Tech Stories:
Entrepreneur Walk of Fame Opens in Kendall Square: Gates, Jobs, Kapor, Hewlett, Packard, Swanson, and Edison Are Inaugural Inductees
Vlingo Lawsuit Charges Nuance With Unfair Competition and Commercial Bribery
Tech Prom, Time Management, and the Future of Marketing: Q&A with Dave Balter
Video Startup 1Minute40Seconds Looks to Help People and Organizations Tell Engaging Stories
SocMetrics Leads Growing Cluster of Boston Startups Trying to Cash In on Social Media Tech
Spark Capital’s Todd Dagres on NY vs. Boston, What’s Beyond Social Media, and Why Tech Investing Is Better Than Making Movies
Yesware’s E-mail Plug-In Works “Down in the Trenches” with Salespeople to Close Deals and Kill Data Entry
How’s That Stretchy, Bendy Stuff Working Out for Ya? MC10 Looks to Turn Flexible Sensors and Solar Cells Into a Growth Business
Anatomy of a $256M Acquisition: The Story of DynaTrace, Compuware, and Bain Ventures
TeraDiode, MIT Lincoln Lab Spinoff, Trying to Create the Future of Laser Weapons & Welding
Top 10 Life Sciences and Energy Stories:
Boston-Power Pulls In $125M, Shifting Focus and Most Operations to China to Get Its Battery Tech Into Electric Vehicles
Fraunhofer CSE, with Roots in Post-WWII Germany, Eyes South Boston Building as Energy Efficiency Test Bed
Xconomist of the Week: Bob Langer’s Advice for Turning Foundation and Government Money Into Startup Success
George Scangos, the Boy from Working Class Boston, on His Road Back to Lead Biogen Idec
Black Coral’s Rob Day Talk Cleantech By Way of IT, Why Evergreen Solar’s Bankruptcy Isn’t the End, and Boston’s Energy Future
Harvard Accelerator Program, Proving Its Mettle with Startups and Pharma Partnerships, Looks to Raise Big New Fund
Acceleron, Celgene Take Aim at Amgen’s Multibillion-Dollar Anemia Market
Stéphane Bancel, Former bioMérieux CEO, Talks Future of Startups, Diagnostics, Pharma
Advanced Cell Technology Starts Human Trials of Embryonic Stem Cells Under Strict FDA Supervision
Zafgen Pockets $33M to Take Obesity Drug Through Next Big Step in Clinical Trials
Trending on Xconomy
Enjoy this? Please share it.
Gregory T. Huang is Xconomy's Deputy Editor, National IT Editor, and the Editor of Xconomy Boston. You can e-mail him at email@example.com.